Trial NCT01659658

View at ClinicalTrials.gov 
Org. Study IDs: C16011
Secondary IDs: 12/LO/1771 2011-005468-10 C16011-CTIL MOH_2017-05-07_000374 NL41603.028.12 U1111-1164-7621

Last trial update was posted on 2023-09-21

MeSH Interventions

Cyclophosphamide Dexamethasone Ixazomib Lenalidomide Melphalan Thalidomide

MeSH Conditions

Amyloidosis

Other Conditions

Relapsed or Refractory Systemic Light Chain Amyloidosis

Stopping Reasons

Sponsor's decision

Limitations And Caveats

N/A

Result Publications

N/A

Annotations

Category Annotations
No annotators decided on categories yet

Intervention Annotations
# Outdated Intervention Condition
Name Route DrugBank ID